Dan McAteer describes his reaction more as a sense of relief than elation when his phone pinged on Monday morning with a push alert reporting that the Oxford AstraZeneca vaccine has up to 90% efficacy.
Several months on from becoming one of thousands of volunteers in trials of the Covid-19 vaccine, the 23-year-old student is trying to comprehend the news that people could be vaccinated as early as next month
“The main thing is not wanting to hope too much, especially after the ups and downs of this year, but there is an underlying relief that this nightmare might finally be over,” he said.
Producing academic work to deadline under lockdown has not been easy. “Doing a one-year master’s from your bedroom is something I don’t recommend,” said McAteer, who had no adverse side-effects through a first month of keeping a diary and beyond.
While somewhat jaded and worried about the ability of the British government not to botch the roll-out of the vaccine – “it’s going…